logo
Group of cities sues Trump administration over new changes to Obamacare enrollment and eligibility

Group of cities sues Trump administration over new changes to Obamacare enrollment and eligibility

CNN01-07-2025
A group of Democratic-led cities sued the Trump administration Tuesday over new changes to the Affordable Care Act that they say will undermine the sweeping health care law and result in nearly 2 million Americans losing health insurance.
The rule, finalized on June 25, shortens the open enrollment period for Americans buying insurance on the marketplace and ends a monthly special enrollment period for people with incomes below 150% of the federal poverty line. It also introduces more preenrollment requirements, such as income verification checks.
The Centers for Medicare and Medicaid Services estimated last month between 725,000 and 1.8 million people could lose coverage due to the rule, but said the changes introduce new 'safeguards' against improper enrollment and overspending.
The lawsuit, filed in federal court in Maryland, was brought by the cities of Chicago, Baltimore and Columbus, Ohio, as well as an association of doctors and a non-profit network of small businesses that rely on the Affordable Care Act marketplace.
They allege that several parts of the new rule violate the ACA and other federal laws, and say the administration ran afoul of federal rulemaking procedures when it created the new policies, including by failing to respond to public comments submitted as the rule was being finalized.
'Rather than reducing the cost of insurance for consumers, or increasing their enrollment rates and benefits, Defendants' new policies will cause at least 1.8 million Americans to lose coverage on the ACA's health insurance Exchanges in 2026 alone and will ultimately result in higher premiums in the long term and higher out-of-pocket costs for the remaining enrollees,' attorneys for the plaintiffs wrote in the lawsuit.
The plaintiffs, represented by attorneys with Democracy Forward, are asking the court to wipe away the parts of the new rule they're challenging.
Spokespeople for CMS and its parent agency, the Department of Health and Human Services, did not immediately respond to a request for comment on the lawsuit.
Advocates for the Trump administration's rule changes say the ACA marketplace is rife with fraud because of expanded subsidies, or tax credits that keep Americans' monthly premiums low. Millions of people are enrolling in those low-cost plans even if their income makes them ineligible for heavily subsidized plans, according to conservative think tank Paragon Health Institute.
Congress expanded those subsidies in 2021 during the Covid-19 pandemic, but the temporary tax credits are set to expire at the end of 2025. The beefed-up subsidies helped drive a record 24 million people to sign up for coverage for 2025.
The new rule is set to take effect in late August. The House version of President Donald Trump's agenda bill would codify the rule into law, though the Senate legislation has different provisions, which would also tighten eligibility for subsidies and increase verification requirements.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

UPDATED: Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology
UPDATED: Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology

Yahoo

time15 minutes ago

  • Yahoo

UPDATED: Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology

Company to Pursue Technologies to Improve Brain Function, Muscle Strength, Bone Health, and Other Longevity Indicators NEW YORK, July 25, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) (the "Company" or "Klotho") announced that it is evaluating the acquisition of several complementary technologies aimed at supporting healthy brain function, organ health, and longevity. In addition to its core programs targeting brain aging and neurodegenerative diseases such as ALS, Alzheimer's, and Parkinson's, the Company is now seeking to expand into adjacent technologies that complement its proprietary anti-aging Klotho platform. The goal is to slow biological aging and reduce the burden of age-related diseases—ultimately promoting a longer, healthier life. "As announced previously, we've begun manufacturing and development of KLTO-101 and KLTO-202," said Klotho CEO Dr. Joseph Sinkule. "We're also exploring other treatments that could support healthy aging and extend human longevity." The human Klotho gene is strongly linked to aging and longevity. Klotho levels decline with age, contributing to age-related disorders such as cardiometabolic disease, neurodegeneration, cancer, sarcopenia (muscle wasting), osteoporosis, and general fatigue. Silencing of the Klotho gene has been shown to accelerate multi-organ deterioration. "The Klotho gene is what we call a master gene," stated Shalom Hirschman, M.D., world-renowned physician and senior consultant to the Company. "The Klotho gene has pleotropic actions modulating many critical cellular pathways including insulin resistance, insulin-like growth factor-1, FOXO3 transcription factors, and Wnt signaling pathways leading to the reduction of inflammatory and mitochondrial oxidative stresses and other cell-damaging mechanisms that can be prevented by two alpha-Klotho protein isoforms – soluble Klotho and secreted-Klotho." "We're assembling a team of scientists, clinicians, and business leaders focused on identifying key longevity indicators," said Jeffrey LeBlanc, Klotho CFO. "This includes evaluating genes and proteins such as alpha-Klotho, beta-Klotho, FOXO3, anti-myostatin, and their isoforms." Dr. Sinkule added, "If people don't die of cancer or trauma, they often succumb to age-related diseases of the brain, heart, kidneys, liver, bone, or muscle. Our mission is to identify and develop complementary assets to delay these outcomes through targeted research and intervention." About Klotho Neurosciences, Inc. Klotho Neurosciences, Inc. (NASDAQ: KLTO), is a biogenetics company focused on the development of innovative, disease-modifying cell and gene therapies using a protein derived from a patented form of the "anti-aging" human Klotho gene (s-KL), and its novel delivery systems to transform and improve the treatment of neurodegenerative and age-related disorders such as ALS, Alzheimer's, and Parkinson's disease. The company's current portfolio consists of its proprietary cell and gene therapy programs using DNA and RNA as therapeutics and genomics-based diagnostic assays. The company is managed by a team of individuals and advisors who are highly experienced in biopharmaceutical product development and commercialization. Investor Contact and Corporate Communications - Jeffrey LeBlanc, CFO, ir@ Website: Forward-Looking Statements: This press release contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements generally are identified by the words "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result," and similar expressions. Without limiting the generality of the foregoing, the forward-looking statements in this press release include descriptions of the Company's future commercial operations. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, such as the Company's inability to implement its business plans, identify and realize additional opportunities, or meet or exceed its financial projections and changes in the regulatory or competitive environment in which the Company operates. You should carefully consider the foregoing factors and the other risks and uncertainties described in the documents filed or to be filed by the Company with the U.S. Securities and Exchange Commission (the "SEC") from time to time, which could cause actual events and results to differ materially from those contained in the forward-looking statements. All information provided herein is as of the date of this press release, and the Company undertakes no obligation to update any forward-looking statement, except as required under applicable law. View original content to download multimedia: SOURCE Klotho Neurosciences, Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Cooler Northern California summer doesn't mean mosquito risk is gone, officials warn
Cooler Northern California summer doesn't mean mosquito risk is gone, officials warn

CBS News

time17 minutes ago

  • CBS News

Cooler Northern California summer doesn't mean mosquito risk is gone, officials warn

A cooler summer in Northern California may have kept mosquitoes out of sight and out of mind, but Placer County officials are warning: don't let your guard down. Crews at the Placer Mosquito and Vector Control District are ramping up efforts as they prepare for the busiest part of mosquito season, which peaks in late summer. They're closely monitoring mosquito activity and tracking the spread of West Nile virus, which is already showing up in the region. "This about four period of the summer is the time when people should take every precaution from getting mosquito bites," said Joel Buettner, General Manager of the Placer Mosquito and Vector Control District. According to the Centers for Disease Control and Prevention, 49 human cases of West Nile virus have been reported across the country so far this year, two of them in California. In Placer County alone, 18 mosquito samples tested positive just last week. Inside the lab in Roseville, crews are trapping and testing mosquitoes from across the county. "When our mosquitos come back we put them in our negative eighty freezer," said Lab Supervisor Casey Hubble. "We do not want them alive during identification and we don't want them alive when we're testing them because they have the potential to carry West Nile virus." What makes this year different is the weather. Fewer scorching-hot days have slightly slowed mosquito activity for now. "The cooler weather that we've had this week is slowing down the behavior of the mosquitos in terms of finding blood meals," Buettner said. "But we expect that it will return back to normal by next week." Officials say public prevention is just as important as lab testing and fieldwork. "You need to know when they're out," Buettner added. "The ones that carry West Nile virus are common in the morning around dawn and dusk. Wearing a repellent that has an EPA-registered ingredient like oil of lemon eucalyptus can help." Residents are also urged to dump and drain standing water around their homes, which are common mosquito breeding grounds. Health experts stress that just one bite is enough to spread infection and say with cases already confirmed in California, personal protection should be a top priority.

Democrats Get Lowest Rating From Voters in 35 Years, WSJ Poll Finds
Democrats Get Lowest Rating From Voters in 35 Years, WSJ Poll Finds

Wall Street Journal

time17 minutes ago

  • Wall Street Journal

Democrats Get Lowest Rating From Voters in 35 Years, WSJ Poll Finds

The Democratic Party's image has eroded to its lowest point in more than three decades, according to a new Wall Street Journal poll, with voters seeing Republicans as better at handling most issues that decide elections. The new survey finds that 63% of voters hold an unfavorable view of the Democratic Party—the highest share in Journal polls dating to 1990 and 30 percentage points higher than the 33% who hold a favorable view.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store